<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30363769</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1741-427X</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>2018</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Evidence-based complementary and alternative medicine : eCAM</Title>                <ISOAbbreviation>Evid Based Complement Alternat Med</ISOAbbreviation>            </Journal>            <ArticleTitle>The Internal Coherence of Breast Cancer Patients Is Associated with the Decision-Making for Chemotherapy and <i>Viscum album</i> L. Treatment.</ArticleTitle>            <Pagination>                <MedlinePgn>1065271</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2018/1065271</ELocationID>            <Abstract>                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">In the present observational study, the influence of internal coherence on shared decision-making for chemotherapy (CTX) and <i>Viscum album</i> L. extracts (VA) treatment in breast cancer patients was evaluated.</AbstractText>                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">Breast cancer patients with a guideline-oriented advice from the tumor board for CTX were included in the study. At first diagnosis (T0) and 6 months later (T1), a questionnaire, the internal coherence scale (ICS), was administered and evaluated. Prior to analysis, patients were classified retrospectively depending on their treatment decision.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">64 primary nonmetastasized breast cancer patients (median age 54.8 years, IQR: 46.3-65.3) were analyzed in this study. At T0, adjusted multivariable linear regression analyses revealed significant low ICS scores in patients rejecting CTX, especially in the ICS subscale &quot;thermo coherence&quot; (p = 0.006). The decision for add-on VA-therapy was associated with low scores for the ICS subscale &quot;inner resilience coherence&quot;, in particular low for the item &quot;courage&quot;. At T1, in the CTX+VA-group the thermo coherence increased significantly (p(d) &lt; 0.01), while in contrast, in the CTX-only group the thermo coherence decreased significantly (p(d) = 0.02).</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Add-on VA-applications in CTX treatment support the thermo coherence of breast cancer patients, revealing a decision option to encourage patients to undergo CTX in combination with additional VA-treatments.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Oei</LastName>                    <ForeName>Shiao Li</ForeName>                    <Initials>SL</Initials>                    <Identifier Source="ORCID">0000-0002-5772-550X</Identifier>                    <AffiliationInfo>                        <Affiliation>Research Institute Havelhöhe, D-14089 Berlin, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Thronicke</LastName>                    <ForeName>Anja</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Research Institute Havelhöhe, D-14089 Berlin, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kröz</LastName>                    <ForeName>Matthias</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Research Institute Havelhöhe, D-14089 Berlin, Germany.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Hospital Havelhöhe, D-14089 Berlin, Germany.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Germany.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Institute for Integrative Medicine, University of Witten/Herdecke, D-58313 Witten/Herdecke, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Herbstreit</LastName>                    <ForeName>Cornelia</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Hospital Havelhöhe, D-14089 Berlin, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schad</LastName>                    <ForeName>Friedemann</ForeName>                    <Initials>F</Initials>                    <Identifier Source="ORCID">0000-0002-6928-6209</Identifier>                    <AffiliationInfo>                        <Affiliation>Research Institute Havelhöhe, D-14089 Berlin, Germany.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Hospital Havelhöhe, D-14089 Berlin, Germany.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>27</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Evid Based Complement Alternat Med</MedlineTA>            <NlmUniqueID>101215021</NlmUniqueID>            <ISSNLinking>1741-427X</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Med Res. 2009 May 14;14(5):223-7</RefSource>                <PMID Version="1">19541580</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Nurs Forum. 2009 Sep;36(5):563-70</RefSource>                <PMID Version="1">19726396</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Complement Med Res. 2018;25(2):92-101</RefSource>                <PMID Version="1">29656290</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2004 Mar-Apr;24(2C):1293-302</RefSource>                <PMID Version="1">15154663</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Forsch Komplementmed. 2006 Oct;13(5):285-92</RefSource>                <PMID Version="1">17057389</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Forsch Komplementarmed Klass Naturheilkd. 2002 Jun;9(3):160-7</RefSource>                <PMID Version="1">12119512</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2017 Jan;67(1):7-30</RefSource>                <PMID Version="1">28055103</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer. 2002;9(3):196-202</RefSource>                <PMID Version="1">12185329</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2017 Apr;32:144-155</RefSource>                <PMID Version="1">28189100</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Clin Cancer Res. 2009 Jun 11;28:79</RefSource>                <PMID Version="1">19519890</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Forsch Komplementarmed Klass Naturheilkd. 2000 Jun;7(3):132-8</RefSource>                <PMID Version="1">10899747</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Qual Life Outcomes. 2009 Jun 24;7:59</RefSource>                <PMID Version="1">19552807</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 1993 Mar 3;85(5):365-76</RefSource>                <PMID Version="1">8433390</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2006 Sep;99(1):35-45</RefSource>                <PMID Version="1">16541318</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Integr Cancer Ther. 2015 Mar;14(2):140-8</RefSource>                <PMID Version="1">25552476</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Soc Sci Med. 1993 Mar;36(6):725-33</RefSource>                <PMID Version="1">8480217</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Forsch Komplementmed. 2013;20(5):353-60</RefSource>                <PMID Version="1">24200825</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1993 Mar;11(3):570-9</RefSource>                <PMID Version="1">8445433</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Complement Med Res. 2018;25(2):85-91</RefSource>                <PMID Version="1">29510405</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Obstet Gynecol Neonatal Nurs. 2014 May-Jun;43(3):382-98</RefSource>                <PMID Version="1">24690072</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Appl Physiol (1985). 1999 May;86(5):1588-93</RefSource>                <PMID Version="1">10233122</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Epidemiol Community Health. 2007 Nov;61(11):938-44</RefSource>                <PMID Version="1">17933950</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2006 Mar-Apr;26(2B):1519-29</RefSource>                <PMID Version="1">16619567</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Integr Cancer Ther. 2012 Sep;11(3):187-203</RefSource>                <PMID Version="1">22019489</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2006 Aug;42(12):1711-4</RefSource>                <PMID Version="1">16806902</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Oncol. 2017 Dec;56(12):1690-1697</RefSource>                <PMID Version="1">28903664</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003297</RefSource>                <PMID Version="1">18425885</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Complement Altern Med. 2011 Aug 28;11:72</RefSource>                <PMID Version="1">21871125</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2015 Jun 08;10(6):e0129181</RefSource>                <PMID Version="1">26053053</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Evid Based Complement Alternat Med. 2014;2014:724258</RefSource>                <PMID Version="1">24672577</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Hyperthermia. 2010;26(7):662-80</RefSource>                <PMID Version="1">20849261</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychooncology. 2013 Dec;22(12):2729-35</RefSource>                <PMID Version="1">23813806</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Phytomedicine. 2011 Jan 15;18(2-3):151-7</RefSource>                <PMID Version="1">20724129</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>02</Month>                <Day>27</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>05</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30363769</ArticleId>            <ArticleId IdType="doi">10.1155/2018/1065271</ArticleId>            <ArticleId IdType="pmc">PMC6181006</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>